Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation  by Cheng, Alec M et al.
Cell, Vol. 95, 793±803, December 11, 1998, Copyright 1998 by Cell Press
Mammalian Grb2 Regulates Multiple Steps in
Embryonic Development and Malignant Transformation
Grb2, Crk, and Nck, have no catalytic activity, but pos-
sess one or more SH3 domains (Mayer et al., 1988;
Lehmann et al., 1990; Lowenstein et al., 1992). Such
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Robert D. Cardiff,§ James C. Cross,*² proteins can serve as adaptors (Koch et al., 1991) by
linking proteins with pTyr and proline-rich motifs. TheWilliam J. Muller,³ and Tony Pawson*²‖
*Samuel Lunenfeld Research Institute prototype for the Grb2 family, SEM-5, has the modular
organization SH3-SH2-SH3 and was identified in Caeno-Mount Sinai Hospital
Toronto, Ontario M5G 1X5 rhabditis elegans as a protein required for signaling from
the LET-23 receptor tyrosine kinase (RTK) to Ras (ClarkCanada
²Department of Molecular and Medical Genetics et al., 1992). Evidence for a physiological downstream
target for Grb2 proteins was initially obtained from anUniversity of Toronto
Ontario M5S 1A8 analysis of the Drosophila homolog of SEM-5, Drk (Oliv-
ier et al., 1993; Simon et al., 1993).Canada
³ Institute for Molecular Biology and Biotechnology Drk plays an essential role in coupling the Sevenless
McMaster University (Sev) RTK to the Ras-MAP kinase pathway. The SH2
Hamilton, Ontario L8S 4K1 domain of Drk binds preferentially to pTyr-X-Asn motifs,
Canada such as those found on Sev (Songyang et al., 1994; Raabe
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University of California at Davis associates with a PPPLPPR motif in the C-terminal tail
Davis, California 95616 of Sos, a protein with a central domain that catalyzes
Ras guanine nucleotide exchange (Raabe et al., 1995).
Genetic analysis indicates that the ability of Drk to link
RTKs to Sos is critical for activation of the Ras pathwaySummary
in vivo. The N-terminal region of Sos, which possesses
Dbl homology and pleckstrin homology (PH) domains,Proteins with SH2 and SH3 domains link tyrosine ki-
may also respond to a regulatory signal (Karlovich etnases to intracellular pathways. To investigate the bio-
al., 1995).logical functions of a mammalian SH2/SH3 adaptor,
The SH2 domain of mammalian Grb2 (Lowenstein etwe have introduced a null mutation into the mouse
al., 1992; Matuoka et al., 1992) binds numerous phos-gene for Grb2. Analysis of mutant embryonic stem
phoproteins, including activated RTKs (Okutani et al.,cells, embryos, and chimeras reveals that Grb2 is re-
1994), docking proteins such as Shc and FRS-2 (Ro-quired during embyrogenesis for the differentiation of
zakis-Adcock et al., 1992; Kouhara et al., 1997), and theendodermal cells and formation of the epiblast. Grb2
cytoplasmic tyrosine kinases Bcr-Abl and FAK (Pender-acts physiologically as an adaptor, since replacing the
gast et al., 1993; Puil et al., 1994; Schlaepfer et al., 1994).C terminus of the Ras activator Sos1 with the Grb2
Grb2 binds two homologs of Drosophila Sos (Sos1 andSH2 domain yields a fusion protein that largely res-
Sos2 [Bowtell et al., 1992]), primarily through its N-termi-cues the defects caused by the Grb2 mutation. Further-
nal SH3 domain (Li et al., 1993; Rozakis-Adcock et al.,more, Grb2 is rate limiting for mammary carcinomas
1993). Stimulation of cells with growth factors leads toinduced by polyomavirus middle T antigen. These data
the association of Grb2±Sos1 complexes with activatedprovide genetic evidence for a mammalian Grb2±Ras
receptors or docking proteins, and this is proposed tosignaling pathway, mediated by SH2/SH3 domain in-
stimulate Ras through the juxtaposition of Sos and Rasteractions, that has multiple functions in embryogene-
at the membrane. Indeed, membrane-targeted variantssis and cancer.
of Sos1 can transform mammalian fibroblasts (Aronheim
et al., 1994). As in Drosophila, it appears that signalsIntroduction
involved in Ras activation can be transmitted through
both the N-terminal and C-terminal regions of mamma-Signaling by protein±tyrosine kinases involves a regu-
lian Sos1 (Byrne et al., 1996). The Sos1 N terminus maylated series of protein±protein interactions mediated by
also modulate Rho family GTPases (Nimnual et al., 1998).modules such as SH2 and SH3 domains (Pawson and
Understanding the biological functions of mammalianScott, 1997). SH2 domains recognize specific phospho-
Grb2 is complicated by the finding that the Grb2 SH3tyrosine (pTyr)-containing motifs (Anderson et al., 1990;
domains potentially bind a number of protein ligands inSongyang et al., 1993), while SH3 domains bind proline-
addition to Sos1 and Sos2. Thus far, there has beenrich motifs that adopt a polyproline type II helix (Feng et
no direct genetic analysis of a mammalian SH2/SH3al., 1994). A subset of SH2-containing proteins, including
adaptor, although a mutation in the Grb2-binding site
of the Met receptor has suggested a role for Grb2 in‖ To whom correspondence should be addressed (e-mail: pawson@ muscle development (Maina et al., 1996). We have there-
mshri.on.ca).
fore examined the biological activity of Grb2 and the# Present address: Departments of Internal Medicine and Pathol-
related protein Grap (Feng et al., 1996; Trub et al., 1997)ogy, Washington University School of Medicine, St. Louis, Missouri
63110. by gene targeting in the mouse.
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Figure 1. Generation of Heterozygous and
Homozygous Grb2 Mutant ES Cell Lines
(A) Targeting of the Grb2 locus. The construct
(1) was used to target the Grb2 gene (2) in the
R1 ES cell line. Homologous recombination
leads to the deletion of a 6 kb genomic region
(stippled box in [2]) containing exon se-
quences encoding the SH3-N and SH2 do-
mains. The targeted allele (3) is detected by
the 59 and 39 probes as shown, with the ex-
pected DNA fragment sizes as indicated (mu-
tant bands bracketed, [4]).
(B) (left) Genomic DNA from individual ES
clones was digested with HindIII and ana-
lyzed in a Southern blot with the 59 probe.
The targeted clone (lane 5) is shown with the
WT and mutant (DGrb2) fragments marked.
(right) Clone 5-8 was subjected to selection
in medium with G418 (0.3 mg/ml to 2.0 mg/ml)
to yield a homozygous mutant line (DGrb2/
DGrb2), as indicated by the loss of the re-
maining WT allele (lane 6).
(C) (left) Cell lysates from WT and homozy-
gous (DGrb2/DGrb2) cells were immunopre-
cipitated with anti-Grb2 antibody (developed
against a peptide from residues 195±217 of
human Grb2) and the precipitates blotted
with anti-Grb2. (right) WT and mutant cell ly-
sates were immunoprecipitated with anti-Grb2
or anti-Sos1 antibodies (as indicated), and
the precipitates were blotted with anti-Sos1.
Results is critically dependent on Grb2. At 7.5 d.p.c., 33% (17/
52) of the decidua observed in the uteri of DGrb2/1
females upon mating to DGrb2/1 males were emptyTargeting of the Grb2 Locus
The Grb2 locus was disrupted in R1 mouse embryonic (Table 1), suggesting that Grb2 null embryos might arrest
after implantation. Indeed, histological analysis of E5.5stem (ES) cells by deleting sequences containing Grb2
decidua obtained from intercrosses of heterozygousexons 2 and 3. Exon 2 encodes residues 27 to 60, which
mutants revealed that about 25% of embryos were ab-comprise much of the SH3-N domain, and exon 3 en-
normal. To pursue the developmental block of Grb2 nullcodes residues 61 to 100, which form an essential part of
embryos, morulae derived from heterozygous inter-the SH2 domain (Figure 1A). Since the remaining exons 1
crosses were cultured in vitro. After 2 days in KSOMand 4 are out of frame, this deletion is expected to
medium, 86% (48/56) of the morulae developed intoresult in a null allele (DGrb2). Two ES clones bearing the
healthy expanded blastocysts. This percentage is con-correctly targeted allele were isolated (Figure 1B), and
sistent with that observed for development of wild-typechimeric mice derived from one clone, 5-8, gave germ-
(WT) blastocysts ex vivo (90%; Bhatnagar et al., 1995).line transmission of the mutant allele. Heterozygous
Thus, the failure of a small percentage of cultured em-DGrb2 mice appeared normal and were intercrossed in
bryos to develop into blastocysts is unlikely to be duean effort to generate homozygous animals. However,
to the DGrb2 mutation. Consistent with this observation,no DGrb2 homozygotes were identified in the resulting
when blastocysts were flushed at E3.5 from Grb2 hetero-progeny at times ranging from 7.5 days postcoitum
zygous intercrosses, embryos of all genotypes were(d.p.c.) to 3 weeks after birth (Table 1). These results
present at the expected Mendelian ratio (Table 1) andsuggested that an early step in embryonic development
appeared phenotypically normal.
The blastocysts were then transferred into individual
microdrops of medium containing 15% FBS and cul-Table 1. Summary of Genotypes Resulting from DGrb2/1
tured for a further 8 days, during which time theyIntercrosses
hatched, attached to the culture dish, and formed out-
1/1 1/2 2/2 Unknown Total
growths. Essentially all (92%; n 5 38) WT and heterozy-
3 weeks 19 29 0 Ð 48 gous blastocysts yielded trophoblast giant cells re-
E9.5 10 16 0 Ð 26 sulting from trophectoderm differentiation, as well as
E7.5 9 26 0 17a 52 expanded inner cell masses (ICM) and outgrowths of
E3.5 (flushed) 5 12 5 3b 25
both parietal and visceral endoderm. Parietal endodermE3.5 (culture) 15 23 10 8b 56
cells migrate away from the ICM in vivo to line the inner
a empty decidua. surface of the parietal yolk sac, whereas visceral endo-
b genotype unknown.
derm cells cover the ICM as it expands into the egg
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Figure 2. In Vitro Outgrowth of Blastocysts
In vitro outgrowths of WT (A) and heterozy-
gous (B) blastocysts, indicating inner cell
mass (ICM), trophectoderm (T), and endo-
derm lineages (visceral endoderm, VE, and
parietal endoderm, PE). Outgrowths of DGrb2/
DGrb2 blastocysts (C and D) lacking an ICM
and endoderm cells. Phase contrast optics;
103 objective.
cylinder. In contrast, the outgrowths from mutant em- endodermal cells. After 2±3 days in culture, the Grb2-
deficient EBs eventually flattened but had limited out-bryos (n 5 10) lacked expanded ICMs and contained
growths of cells at the edges of the colonies (Figure 3B).only very few, if any, endodermal cells, though tropho-
The differentiation of endoderm can also be examinedblast giant cells were normal (Figure 2; Table 2). Together
by an adherent assay in which ES cells are seeded onthese data suggest that Grb2 mutants form blastocysts
culture dishes, maintained for 8±10 days, and inducedthat are able to implant but fail to develop thereafter
to differentiate for 2 days in LIF-free medium. As showndue to defects in ICM survival and/or endoderm differen-
in Figures 3C and 3D, the WT, but not the Grb2-deficient,tiation.
colonies produced an outer layer of visceral endoderm.
The potential of DGrb2/DGrb2 ES cells to undergo inGrb2-Deficient ES Cells Proliferate Normally but
vitro differentiation was also examined by maintainingAre Defective in Endoderm Differentiation
LIF-deprived ES cells in suspension culture. The WT ESTo determine if the defects observed in the blastocyst
cells formed typical late-stage EBs with a peripheralcultures were due to a failure of the ICM to expand or
columnar layer of visceral endoderm surrounding inter-to a specific block in endoderm development, ES cells
nal mesenchyme (Figure 3E). In contrast, Grb2-deficienthomozygous for the DGrb2 mutation were isolated (Fig-
cells gave rise to compact and homogenous structuresure 1B). Two DGrb2/DGrb2 clones, A4 and A9, were
that failed to produce visceral endoderm and did notidentified and subsequently found to display the same
cavitate (Figures 3F and 3G). The lack of endodermphenotype. Whereas Grb2 and associated Sos1 could
development was further investigated by immunostain-be readily detected in WT cells, no Grb2 was observed
ing of cryosections of EBs with antibody to laminin, anin the mutant cells (Figure 1C).
extracellular matrix protein that is produced by endo-The growth rate of DGrb2/DGrb2 ES cells in culture
derm cells (Stephens et al., 1995). As shown in Figuresmedium with 15% FBS was comparable to that of WT
3H±3K, after 4 days in culture DGrb2/1 EBs expressedES cells (data not shown), suggesting that Grb2 does
laminin in a region underlying the presumptive endo-not play a critical role in ES cell proliferation or survival.
derm, whereas none of the Grb2-deficient EBs stainedTo test the role of Grb2 in endoderm differentiation,
positive for laminin. These results indicate that Grb2ES cells were induced to differentiate by removal of
signaling is not required for ES cell proliferation but isleukemia inhibitory factor (LIF) and cultured as single-
necessary for the differentiation or maintenance of the
cell suspensions in bacterial culture plates for 2 days.
endodermal lineage. The inability of Grb2-deficient ES
The resulting embryoid bodies (EBs) were transferred
cells to differentiate into endoderm raised the possibility
to a tissue culture dish. All the WT EBs attached to the that Grb2 deficiency may completely block the ability
dish within 1 hr and immediately flattened, exhibiting of ES cells to differentiate. To examine this issue, we
active cell growth and migration of parietal endoderm performed immunostaining of EBs for cytokeratin ex-
and a collar of visceral endoderm cells at their margins pression with the TROMA-1 antibody. Previous analysis
(Figure 3A). In contrast, DGrb2/DGrb2 EBs failed to at- has shown that cytokeratin is synthesized in differenti-
tach to the dish until cultured for 6 hr and did not yield ated cells such as trophoblasts, but not in the undifferen-
tiated ICM (Oshima et al., 1983). Staining of cryosections
of DGrb2/1 EBs revealed detectable levels of cytokera-Table 2. Cell Types Derived from Cultured Blastocysts from
tin in endoderm cells surrounding the differentiating EBsDGrb2/1 Intercrosses
(Figures 3L and 3M). However, while Grb2-deficient EBs
1/1 1/2 2/2
did not give rise to endoderm, many cells at the periph-
trophectoderm 15/15 23/23 10/10 ery of DGrb2/DGrb2 EBs expressed cytokeratin (Figures
ICM expansion 14/15 22/23 0/10 3N and 3O). These results suggest that the absence of
endoderm 14/15 23/23 0/10
Grb2 does not globally block all aspects of stem cell
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differentiation, consistent with the observation that
Grb2-deficient blastocysts yield cells of the trophoblast
lineage.
The Grb2±Ras Pathway Is Required
for ES Cell Differentiation
To dissect the signaling pathway regulated by Grb2 dur-
ing ES cell differentiation, a construct containing the
human b-actin promoter and a puromycin selection cas-
sette was used to direct expression of WT murine Grb2
cDNA in the Grb2-deficient ES cells. Puromycin-resis-
tant colonies were then subjected to differentiation on
tissue culture dishes. While the mock transfected cells
exhibited no endoderm differentiation (Figure 4Aa), many
of the cells transfected with WT Grb2 cDNA yielded
colonies that underwent endoderm differentiation when
deprived of LIF (compare Figures 4Aa and 4Ab). This
functional rescue indicates that the defect exhibited by
homozygous DGrb2 ES cells is due solely to their loss
of Grb2. The ability of Grb2 to support endoderm differ-
entiation was abrogated by substitutions in either the
SH3-N domain or SH2 domain, which block their ability
to bind proline-rich motifs or pTyr-containing sequences,
respectively (Figure 4B1±6). Interestingly, a Grb2 cDNA
with a mutation that inactivates the C-terminal SH3
(SH3-C) domain induced endodermal differentiation in
Grb2-deficient cells with about 40% the efficiency of
WT Grb2 (lane 3). ES cell differentiation is therefore de-
pendent on the concerted functions of the Grb2 SH2
and SH3-N domains, but is less reliant on the SH3-C
domain. By inference, the ability of Grb2 to couple a
pTyr-containing protein to a polypeptide with a proline-
rich motif is important in a pathway involved in endo-
derm formation.
The Grap gene is predominantly expressed in lymphoid
tissues and encodes a protein very similar to Grb2 (Feng
et al., 1996; Trub et al., 1997). Mice homozygous for a
null mutation in Grap do not display any obvious pheno-
type (A. M. C. and T. P., unpublished results), raising
plated on tissue culture dishes, grown for 8 days in LIF-supple-
mented medium, and induced to differentiate by LIF withdrawal.
After 2 days in culture, colonies from WT ES cells differentiated to
yield a layer of endodermal cells ([C], cells fixed for 5 min in 4%
formaldehyde and stained for 10 min in Giemsa; visceral endoderm
cells marked ªVEº, and undifferentiated ES cells marked ªESº). Out-
growths of endoderm were absent from colonies of DGrb2/DGrb2
ES cells (D).
(E±G) In a suspension assay, WT ES cells grown in LIF-free medium
for approximately 10±12 days in a bacterial plastic petri dish gave
rise to EBs that expanded significantly in size, became cavitated
Figure 3. Grb2-Deficient ES Cells Fail to Differentiate into Endoder- (CA), and yielded a peripheral columnar layer of visceral endoderm
mal Cells In Vitro (VE) surrounding the embryoid bodies ([E], histological section
In vitro differentiation of ES cells was examined with three different stained with hematoxylin and eosin. Arrows point to VE cells). Em-
approaches. bryoid bodies derived from DGrb2/DGrb2 cells appeared compact,
(A and B) Outgrowths of endoderm from embryoid bodies (EBs). ES undifferentiated, and lacked VE (F and G).
cells were cultured in LIF-free medium as a single-cell suspension (H±O) Immunofluorescence staining of cryosections of 4-day-old
for 2 days to yield EBs, which were seeded onto a 24-well plate EBs from Grb21/2 and Grb22/2 ES cells. EBs immunostained for
and cultured for a further 2 days. All WT (1/1) EBs (A) produced laminin (I, K) and cytokeratin (M, O) are shown. Panels on the left
active outgrowth of visceral endoderm cells (VE) (circle marks the (H, J, L, N) show nuclear staining with bisbenzimide of the corre-
origin of the seeded EBs; the region that contains undifferentiated sponding sections on the right. The arrow in (H) identifies the pre-
ES cells is marked ªESº) . Grb2-deficient (2/2) EBs did not yield sumptive endoderm, and that in (I) identifies the underlying laminin.
visceral endoderm (B). The arrows in (M) and (O) identify cells that stained positively for
(C and D) In an adherent culture assay, individual ES cells were cytokeratin.
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the possibility that Grb2 and Grap are functionally redun-
dant. Since RT-PCR analysis suggested that the Grap
gene is not expressed in ES cells (data not shown),
we tested the effects of expressing Grap in the Grb2-
deficient cells. Grap expression restored the ability of
Grb2-deficient ES cells to undergo endoderm differenti-
ation, albeit with a lower efficiency than WT Grb2 (Figure
4B). Hence, in this assay Grap and Grb2 have overlap-
ping biological activities.
To test whether Grb2 might act through the Ras path-
way during ES cell differentiation to endoderm, we trans-
fected Grb2-deficient cells with an activated variant of
H-Ras (G12V). The activated H-Ras drove endoderm
differentiation in Grb2-deficient ES cells, with an effi-
ciency only slightly lower than WT Grb2 cDNA (Figures
4Ac and 4B). Moreover, G12V H-Ras induced differentia-
tion of Grb2-deficient ES cells even in the presence
of LIF, which normally represses ES cell differentiation
(data not shown). These results are consistent with the
notion that Grb2 functions through activation of the Ras
pathway in differentiating ES cells and accord with previ-
ous evidence indicating that Ras activation accompan-
ies the differentiation of cells resembling primitive endo-
derm in F9 embryonal carcinoma cells (Yamaguchi-Iwai
et al., 1990).
Fusion of a Truncated Sos1 Protein to the Grb2
SH2 Domain Suppresses the Defect
in Grb2-Deficient ES Cells
A model proposed for Grb2 signaling suggests that the
physical association of Grb2 SH3 domains with proline-
rich motifs in the C-terminal region of Sos1 (Figure 5A)
recruits the Ras guanine nucleotide exchange factor
(GEF) into a complex with pTyr-containing proteins, Figure 4. Dissection of the Grb2±Ras Signaling Pathway Required
for Differentiation of ES Cellsthereby positioning Sos1 at an appropriate location to
(A) The effect of expressing Grb2 or G12V H-ras on the differentiationactivate Ras. To address this issue, we deleted residues
defect in DGrb2/DGrb2 ES cells. Cells transfected with vector DNA1092±1319 from the C-terminal tail of Sos1, including
(a), a Grb2 cDNA expression construct (b), or a 6.6 kb G12V H-rasall the proline-rich motifs, and joined this truncated Sos1
genomic fragment (c) were plated on tissue culture dishes, grown
molecule to the Grb2 SH2 domain (residues 53±164) to for 8 days, and then in the absence of LIF for another 3 days. The
generate the chimeric tSosSH2 protein (Figure 5A). An differentiation of endodermal cells was revealed by active out-
expression construct encoding this chimeric protein effi- growths at the margins of the colonies (b and c), which could be
easily visualized as a lightly stained area at the periphery of theciently rescued endoderm differentiation in Grb2-defi-
outgrowth (arrows in b and c).cient cells (Figure 5B). Since deletion of the C-terminal
(B) Quantitation of the abilities of WT or mutant Grb2 cDNAs totail might potentially result in constitutive Sos1 activa-
rescue the differentiation defect of DGrb2/DGrb2 ES cells, measured
tion (Wang et al., 1995), we tested whether the biological as the percentage of transfected DGrb2/DGrb2 colonies that under-
activity of the chimeric protein depends on the presence went endoderm differentiation. The activity of the Grap cDNA was
of a functional SH2 domain by mutating an Arg required also analyzed.
for pTyr recognition in tSosSH2 (corresponding to Arg-
86 in Grb2) to Lys (Figure 5A). The chimeric protein with
a nonfunctional SH2 domain (tSosR86K) did not rescue formed from tSosSH2-, but not tSosR86K-transfected,
endodermal differentiation (Figure 5B). These results cells produced a visceral endoderm layer on their pe-
suggest that the provision of Sos1 with the Grb2 SH2 riphery. The identity of these cells was further confirmed
domain is sufficient to suppress the ES cell defect by specific staining for a-fetoprotein, a marker of vis-
caused by ablation of Grb2, arguing that a key physio- ceral endoderm (Figure 5Cc). Thus, the expression oflogical role of WT Grb2 during endoderm differentiation tSosSH2 can compensate for the loss of Grb2 and effec-
is to recruit Sos1 or a related GEF to pTyr-containing tively restore the differentiation program of Grb2 mutant
proteins. ES cells.
We also investigated the ability of tSosSH2 to rescue
visceral endoderm differentiation of Grb2-deficient cells
Grb2 Is Required during Development of the Epiblastby analyzing the development of EBs in suspension cul-
To circumvent the initial block in endoderm differentia-ture. After 2 weeks of culture, Grb2 null cells transfected
tion resulting from the absence of Grb2, aggregationwith tSosSH2 gave rise to EBs that displayed differenti-
ated features (Figures 5Ca and 5Cb). Most important, EBs chimeras were generated by incubating ES cells with
Cell
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Figure 5. The Grb2 SH2 Domain Can Substi-
tute for the Proline-Rich C-Terminal Region
of Sos1 in Mediating Signals that Regulate
ES Cell Differentiation
(A) A schematic showing the organization of
the DH, PH, catalytic (CAT) domains, and the
proline-rich tail of Sos1. The C-terminal re-
gion (from residues 1092±1319) was substi-
tuted with a WT or mutant Grb2 SH2 domain
(R86K) to generate the tSosSH2 or tSosR86K
chimeric constructs, respectively.
(B) DGrb2/DGrb2 cells were transfected with
tSosSH2 or tSosR86K expression constructs
and tested for their potential to differentiate
into endodermal cells. The activities of these
constructs, measured as the percentage of
transfected colonies that produced endo-
derm cells, were compared to that of the WT
Grb2 cDNA.
(C) Embryoid bodies formed by DGrb2/DGrb2
ES cells transfected with tSosSH2 were ex-
amined for their differentiation potential ([a]
and [b], histological sections stained with
hematoxylin and eosin; arrows mark the vis-
ceral endoderm layer). Endoderm was distin-
guished from the inner cells by staining
with an antibody to a-fetoprotein (rabbit anti-
mouse), followed by a TRITC-conjugated
secondary antibody (anti-rabbit IgG) (c). Nu-
clear staining with bisbenzimide (d) revealed
individual cells throughout the embryoid
body, in contrast to the specific staining of
endoderm by a-fetoprotein in (c).
WT morulae. During the development of chimeric em- residing on the inner surface of the epiblast (Figures 6Be
and 6Bf).bryos, the extraembryonic endoderm lineage is fated to
be derived from the WT morula cells, allowing develop- Aggregation chimeras were also generated using
Grb2 mutant ES cells that had been transfected withment to proceed beyond E4.5 of gestation. Hence, the
developmental potential of the ES cells at later stages the WT Grb2 cDNA and previously shown to regain en-
doderm differentiation in vitro (Figure 4). Both whole-can be studied. Clumps of heterozygous or homozygous
mutant ES cells were aggregated with WT morulae that mount analysis (Figures 6Bc and 6C) and tissue sections
(Figure 6Bg) showed a strong contribution of these EScontain the Rosa-26 LacZ transgene (Figure 6A) and
then transplanted into pseudopregnant females until cells to the E7.5 chimeric embryos, indicating that rein-
troduction of WT Grb2 into the Grb22/2 ES cells restoresE7.5 of gestation, when whole embryos were fixed and
stained for b-galactosidase activity. Under these cir- their ability to contribute to the epiblast. These data
indicate that Grb2 is required during the developmentcumstances, ES cell±derived tissues will be unstained,
whereas morula-derived cells will stain blue. Whole- of the epiblast layer and reveal that Grb2 has multiple,
sequential functions during mammalian embryonic de-mount analysis revealed that heterozygous ES cells
readily contributed to the developing chimeric embryos velopment.
We also investigated whether the tSosSH2 fusion pro-(Figures 6Ba and 6C), whereas Grb2-deficient ES cells
were not easily detected in the embryo (Figures 6Bb and tein could substitute for Grb2 in guiding epiblast devel-
opment. To this end, chimeric embryos were generated6C). Sectioning of these embryos showed that hetero-
zygous ES cells contributed to both the developing epi- using Grb2-deficient ES cells that had been transfected
with the tSosSH2 expression construct. Two individualblast and mesoderm of the embryo, while the homozy-
gous mutant ES cells were not found in any recognizable clones were tested and both contributed to the epiblast
and mesoderm in the developing embryos (Figures 6Bdembryonic tissues, but instead formed a group of cells
Regulation of Growth and Differentiation by Grb2
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Figure 6. Chimeric Analysis with Grb2 Mu-
tant ES Cells Reveals Requirement for Grb2
during Development of the Epiblast Layer
(A) A schematic depicting the generation of
chimeric embryos through aggregation of the
LacZ-positive Rosa-26 morulae with the
LacZ-negative mutant ES cells.
(B) Examples of whole-mount (a±d) and histo-
logical (e±h) views of E7.5 chimeras gener-
ated by aggregating Rosa-26 morulae with
ES cells that are heterozygous mutant (a and
e), homozygous mutant (b and f), homozy-
gous mutant transfected with Grb2 cDNA (c
and g), or homozygous mutant transfected
with tSosSH2 cDNA (d and h). Arrow in (f)
points to a group of LacZ-negative Grb22/2
cells residing on the inner surface of the epi-
blast. All embryos are shown with the anterior
towards the left. The extraembryonic region
that is entirely derived from the LacZ-positive
Rosa-26 morulae is demarcated along each
embryo (a±d). In (d), the orientation of the
transverse section shown in (h) is marked
(X-Y). An example of the disorganized epi-
blast/mesoderm is marked in the boxed area.
end, endoderm; epi, epiblast; me, mesoderm;
exe, extraembryonic region.
(C) Contribution of mutant ES cells to embry-
onic tissues. A comparison of the percent-
ages and actual numbers of chimeric em-
bryos that exhibited significant contribution
by the LacZ(2) mutant ES cells is shown in
the bar chart. Embryos containing a limited
number of mutant cells that were detectable
only under the microscope (see Figure 6Bf,
for example) are not included in this plot.
Seven out of eighteen of the chimeric em-
bryos generated with the DGrb2/DGrb2 ES
cells exhibited such a limited contribution of
mutant ES cells.
and 6C). However, these tissues lacked the distinct or- mice were crossed to DGrb2/1 females, and the re-
ganization observed in normal embryos (compare Fig- sulting female littermates were scored for mammary tu-
ures 6Be±6Bh). These data indicate that the tSosSH2 mors. As previously reported, tumors started to appear
fusion protein can rescue the ability of Grb22/2 cells to in virgin MT1 mice within 4 weeks of age; by 35 days,
contribute to the epiblast but cannot entirely substitute 50% of the mice had developed tumors, and by 40 days,
for Grb2 in regulating development of the mouse embryo. essentially all such transgenic mice had palpable tumors
(Figure 7A). In contrast, MT-transgenic littermates that
were heterozygous for the DGrb2 mutation were essen-Grb2 Is Rate Limiting for Mammary Carcinomas
tially free of mammary tumors at 40 days, and only 50%Induced by Polyomavirus Middle T Antigen
of the mice had developed tumors by 54 days after birthIn Drosophila, signaling by the Sev RTK is sensitive to
(Figure 7A). Thus, the onset of mammary tumorigenesisthe dosage of Drk (Olivier et al., 1993). To test if hetero-
is delayed in the DGrb2/1 background.zygosity for the DGrb2 mutation may compromise onco-
Tumor formation was also examined by whole-mountgenic signals, we employed a mouse strain carrying a
analysis of mammary fat pads from 3- to 8-week-old MT-transgene in which the polyomavirus middle T antigen
transgenic mice that were either WT or heterozygous for(MT) is transcribed from the mouse mammary tumor
the DGrb2 mutation. The mammary glands of 6-week-virus long terminal repeat (Guy et al., 1992). In cell cul-
old MT-transgenic females contained multifocal epithe-ture, MT is phosphorylated by Src family kinases and is
lial mammary tumors that obscured the tubular architec-subsequently recognized by several signaling proteins,
ture of the breast (Figure 7Bd). In contrast, the mammaryincluding Shc, which binds through its PTB domain to
glands of MT1;DGrb2/1 mice at the same age appearedan NPXpY motif at Tyr 250 of MT (Dilworth et al., 1994;
relatively normal, although small foci of tumors werevan der Geer et al., 1995). This leads to Shc phosphoryla-
evident (Figure 7Bc). Histological sections revealed thattion at Tyr 239/240 and recognition by the Grb2 SH2
MT transgenic mice in the DGrb2/1 background had adomain, potentially activating Ras (van der Geer et al.,
considerably reduced growth of tumorigenic epithelial1996; Blaikie et al., 1997). To investigate the possible role
of Grb2 in MT-induced carcinomas, male MT-transgenic tissues during the first 40 days of life (compare Figures
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tyrosine kinases. Here we have tested these hypotheses
by introducing germline mutations into the genes encod-
ing the mouse Grb2 and Grap adaptors.
The Grb2 Signaling Pathway Primarily Regulates
Differentiation, Rather Than Proliferation,
in the Early Mouse Embryo
Development of preimplantation stage embryos from
the morula into the blastocyst requires differentiation of
some cells into the trophoblast lineage and allocation
of remaining cells to the ICM. This event occurs normally
in the Grb2 null embryos. After the blastocyst begins to
implant within the uterine wall at approximately E4.5 of
gestation, the ICM develops into the egg cylinder, which
requires the differentiation of a portion of ICM cells into
endoderm. It is this event that is blocked by the Grb2
null mutation. As with the Grb2-deficient embryos, ho-
mozygous DGrb2 ES cells were unable to differentiate
into parietal and visceral endoderm. Since endoderm is
critical for the subsequent development of the embryo
beyond E5, the failure of Grb2-deficient cells to yield
endodermal cells likely explains the early developmental
arrest observed for Grb2 mutant embryos.
The upstream extracellular factors that signal through
Grb2 in the early embryo are unknown. However, the
defects exhibited by Grb2 mutant blastocysts are remi-
niscent of mouse embryos lacking b1 integrin (Stephens
et al., 1995) and also resemble phenotypes caused by
mutations in genes for the EGF-receptor (Threadgill et
al., 1995), FGFR2 (Arman et al., 1998), or FGF4 (Feldman
et al., 1995). These observations suggest that Grb2 may
mediate phosphotyrosine signaling initiated by both ad-
hesion molecules and soluble factors that are critical in
the development of mouse embryos beyond the blasto-
cyst stage. The possibility that Grb2 might have several
distinct functions during early embryogenesis was ana-Figure 7. Gene Dosage Effect of Grb2 on Polyomavirus Middle T
Antigen±Mediated Transformation of Mammary Epithelial Cells lyzed using chimeric embryos derived by the aggrega-
tion of Grb2-deficient ES cells with WT morulae. These(A) Littermates that were transgenic for MT (MT1) in either the WT
or the heterozygous DGrb2 background (MT1;DGrb2/1) were exam- experiments have defined a role for Grb2, subsequent
ined for the development of mammary tumors starting at the age to endoderm differentiation, in the transformation of the
of 4 weeks. Tumors were detected by palpating the five pairs of ICM into the epiblast.
mammary glands on each mouse.
These results have several intriguing and surprising(B) Whole-mount (a±d) (53) and histological (e±h) (403) images of
implications. First, it appears that Grb2 is not requiredmammary glands 6 weeks after birth from WT (wt), DGrb2/1,
for the proliferation of ES cells or cells in the early em-MT1;DGrb2/1, and MT1 littermates. The growth in the mammary
tree from the DGrb2/1 mouse (b and f) had not filled the entire fat bryo, but rather has specific functions in guiding succes-
pad, had actively growing terminal buds (arrow), and was signifi- sive differentiation events. Second, these data identify
cantly retarded in relation to the WT (a) that had filled the fat and a key intracellular signaling pathway that conveys infor-
was quiescent. The mammary gland, however, was histologically
mation from the cell surface to induce differentiationnormal (e and f). MT1 mice in DGrb2/1 background exhibited fully
of the endoderm and epiblast cell layers, and therebydeveloped mammary trees with dilated ducts with relatively few side
organizes development of the early embryo. This is es-branches and scattered small focal lesions (arrow, [c]). Some of the
cystic ducts and lobules were lined by multiple layers of dysplastic pecially significant, as little is known concerning the
epithelium (arrow) (g). In contrast, the gland from the 6-week-old cytoplasmic pathways that operate in early embryogen-
MT-transgenic animal was fully developed with multiple focal lesions esis, and the signaling events controlling epiblast forma-
(arrow, [d]) that were filled with dysplastic epithelium (h).
tion have been obscure. Third, the fact that Grb22/2 cells
express some molecular markers of endoderm differen-
7Bg and 7Bh). These results argue that Grb2 is rate lim- tiation, but not others, implies that there may be multiple
iting for the formation of mammary carcinomas induced signaling events controlling the fate of these cells. Thus,
by MT. the Grb2 pathway directs specific facets of mouse de-
velopment.
Discussion
Direct Evidence for Modular Protein
Mammalian SH2/SH3 adaptors have been proposed as Interactions in the Mouse Embryo
having important functions in physiological signaling To test whether Grb2 functions in vivo through SH3-
mediated recruitment of a Ras GEF, we have replacedpathways and malignant transformation by deregulated
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the proline-rich C-terminal region of Sos1 with the Grb2 Shc with Grb2, promote the development of mammary
carcinomas. The receptor tyrosine kinase ErbB2 is com-SH2 domain. Remarkably, our results show that this
chimeric protein restores endoderm differentiation in monly expressed in human breast and ovarian cancers
and has docking sites for both the Shc PTB domainGrb2-deficient cells and that its activity is dependent
upon a functional SH2 domain. Furthermore, the tSosSH2 and the Grb2 SH2 domain, raising the possibility that
signaling through Grb2 may also contribute to the devel-protein supports most aspects of epiblast formation in
vivo. The finding that fusing the Grb2 SH2 domain onto opment of some human cancers.
Sos1 can overcome the requirement for endogenous
Grb2 in early embryogenesis provides direct evidence SH2/SH3 Domain Interactions Regulate
that mammalian Grb2 is required to link tyrosine kinases Mammalian Developmental Pathways
to Sos. By artificially creating this key protein±protein A wealth of evidence indicates that protein±protein inter-
interaction in Grb2 mutant ES cells, both in vitro and in actions, involving modules such as SH2 and SH3 do-
chimeric embryos, we have shown that the modular mains, mediate the activation of specific intracellular
SH2/SH3 domain Grb2 protein indeed functions as an biochemical pathways by cell surface receptors. Here
adaptor in the mammalian embryo. These data also es- we have defined roles for the Grb2 adaptor in specific
tablish that a Ras-GEF, rather than some other SH3- aspects of embryonic development in the mouse and
binding protein, is the principal Grb2 target in the early have shown that the Grb2 pathway is subverted in mam-
mouse embryo. The observation that an activated H-ras mary cancers. These results indicate that mammalian
transgene drives endodermal differentiation in DGrb2/ SH2/SH3 adaptors such as Grb2 have multiple activities
DGrb2 ES cells, even in the presence of LIF, strongly in normal and oncogenic signaling and require the con-
suggests that Grb2 functions to activate Ras in these certed actions of distinct modules to exert their biologi-
cells. These results indicate that the Ras signaling path- cal effects.
way is essential for the early specification of embryonic
tissues, a conclusion that may have been previously
Experimental Procedures
thwarted by the presence of three Ras genes and multi-
ple Sos genes (Wang et al., 1997) with potentially redun- Construction of the Null Allele and Gene Targeting
dant functions in mice. in R1 ES Cells
The Grb2 targeting vector was constructed using the 4.8 kb BamHI±The ability of tSosSH2 to act in place of Grb2 begs
EcoRI fragment as the right arm and the 1.4 kb EcoRI±XbaI fragmentthe question as to why a separate adaptor is normally
as the left arm (Figure 1A). Gene targeting of R1 ES cells was asemployed to bridge tyrosine kinases to Sos. Compel-
described (Nagy et al., 1993; Wood et al., 1993).
lingly, while the tSosSH2 fusion protein allows Grb22/2
ES cells to undergo endoderm differentiation and some
Genotyping of Mutant and WT Alleles by Southern
aspects of epiblast development, it fails to organize the and PCR Analysis
epiblast and mesoderm into a normal architecture, sug- Detection of the DGrb2 and WT alleles by PCR analysis was per-
gesting that the fusion protein lacks some biological formed with primers XhoB, E47-80T, and Neo1. Primers XhoB and
E47-80T amplify a WT 550 bp fragment that is deleted by the nullfunction provided by Grb2. Grb2 has two potential activi-
mutation, whereas Neo1 and XhoB amplify a 725 bp fragment spe-ties that cannot be replicated by the tSosSH2 fusion.
cific for the mutant allele.First, it has two SH3 domains that may bind multiple
partners that regulate distinct pathways. This is sug-
Blastocyst Culturegested by the finding that, in contrast to the SH3-N
domain, the SH3-C domain is neither necessary nor suf- Grb2 heterozygous females were superovulated, and fertilized em-
ficient for ES cell endoderm differentiation. Second, the bryos were obtained by flushing oviducts at E2.5 with M2 medium.
expression of a separate adaptor also allows for regula- Healthy morulae were transferred into KSOM medium for 48 hr,
378C, 5% CO2. Expanded blastocysts were then transferred intotion of SH3-mediated interactions, to which the fusion
individual 10 ml microdrops of ES cell medium (no LIF) under paraffinprotein would be resistant. These data argue that a phys-
oil for a further 8 days. Outgrowths were photographed, scored forically distinct adaptor is important to achieve the full
presence of ICM, trophectoderm, and endoderm cells, and then
range of Grb2 signaling. transferred to 500 ml tubes in 10 ml PCR ProK buffer and genotyped
by standard PCR analysis.
Grb2 Signaling Stimulates Mammary Cancer In Vitro Differentiation of ES cells
We have tested the role of Grb2 in the induction of In suspension culture, ES cell colonies were trypsinized and dis-
persed as a single-cell suspension in 15 ml of LIF-free culture me-mammary carcinomas by polyomavirus MT. Previous
dium in plastic bacterial culture dishes and cultured at 378C/5%work has suggested that the interaction of both Shc and
CO2 for 8±12 days. EBs derived from the suspension culture werephosphatidylinositol 39-kinase with MT is important for
harvested with a pipette and pooled together in PBS. For histology,the rapid development of mammary carcinomas in
EBs were washed once in PBS, fixed for 10 min in 4% paraformalde-
transgenic mice (Webster et al., 1998). Since the associ- hyde, washed with PBS, and kept at 48C before embedding and
ation of Shc with Grb2 contributes to the transformation sectioning.
For adherent culture of ES cells, ES colonies were trypsinized toof cultured cells by MT (Blaikie et al., 1997), it is possible
yield a single-cell suspension. Two hundred to five hundred cellsthat Grb2 plays a role in MT-induced breast cancers in
from this suspension were seeded onto gelatin-coated tissue culturevivo. Our data suggest that Grb2 is indeed rate limiting
plates containing 15 ml of LIF-containing culture medium and incu-for tumor development, since the onset of tumors is
bated at 378C/5% CO2 for 8±10 days. Differentiation of ES cells wassignificantly delayed in a DGrb2/1 background. These initiated by culturing the colonies in LIF-free media for 2±4 days.
data support a model in which the recruitment of Shc Alternatively, individual early differentiated EBs derived from sus-
pension cultures (grown for 2±4 days) were transferred to 24-wellto MT, and subsequent association of phosphorylated
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